Development of natural anti-tumor drugs by microorganisms

Journal of Bioscience and Bioengineering

Volumn 111, Issue 5, 2011, Pages 501-511

  Chang, Chia Che ^a,b   Chen, Wei Chuan ^c   Ho, Tsing Fen ^d   Wu, Ho Shing ^c   Wei, Yu Hong ^c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c YUAN ZE UNIVERSITY   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Anti tumor activities; Cancer; Microbial production system; Natural anti tumor drugs; Prodigiosin (PG)

Indexed keywords

ANTI-TUMOR ACTIVITIES; ANTITUMOR DRUGS; CANCER; MICROBIAL PRODUCTION; PRODIGIOSIN;

BACTERIOLOGY; BIODIVERSITY; BIOTECHNOLOGY; DISEASES; MAMMALS; METABOLITES; PRODUCTION ENGINEERING; TUMORS;

BACTERIA;

ALEMTUZUMAB; AMRUBICIN; ANTINEOPLASTIC AGENT; BECATECARIN; BETA GLUCAN; BEVACIZUMAB; BUTYL META CYCLOHEPTYLPRODIGININE; BUTYLCYCLOHEPTYLPRODIGININE; CETUXIMAB; CYCLOPRODIGIOSIN; ELSAMIRUCINI; METACYCLOPRODIGIOSIN; MEVINOLIN; NAVELBINE; NONYLPRODIGIOSIN; PACLITAXEL; PANITUMUMAB; PRODIGIOSIN; ROMIDEPSIN; SIMVASTATIN; SPICAMYCIN; SURFACTANT; TARTROLON D; TOSITUMOMAB; UNCLASSIFIED DRUG; UNDECYLPRODIGIOSIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOREACTOR; CANCER INHIBITION; CELL CYCLE ARREST; CULTURE MEDIUM; DRUG DECOMPOSITION; DRUG FORMULATION; DRUG ISOLATION; DRUG MANUFACTURE; DRUG PURIFICATION; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG METASTASIS; NONHUMAN; PURIFICATION; REVIEW; SERRATIA MARCESCENS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOREACTORS; CELL CYCLE; CULTURE MEDIA; FERMENTATION; INDUSTRIAL MICROBIOLOGY; MOLECULAR STRUCTURE; NEOPLASMS; PRODIGIOSIN; SERRATIA MARCESCENS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; SERRATIA MARCESCENS;

EID: 79954959102     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2010.12.026     Document Type: Review

References (115)

1. Takahashi H., Aoyagi K., Nakanishi Y., Sasaki H., Yoshida T., Honda H. Classification of intramural metastases and lymph node metastases of esophageal cancer from gene expression based on boosting and projective adaptive resonance theory. J. Biosci. Bioeng. 2006, 102:46-52.
2. Tokumitsu A., Wakitani S., Takagi M. Noninvasive discrimination of human normal cells and malignant tumor cells by phase-shifting laser microscopy. J. Biosci. Bioeng. 2010, 109:499-503.
3. Souweidane M.M., Krieger M.D., Weiner H.L., Finlay J.L. Surgical management of primary central nervous system germ cell tumors: proceedings from the Second International Symposium on Central Nervous System Germ Cell Tumors. J. Neurosurg. Pediatr. 2010, 6:125-130.
4. Kim K.Y., Chung H.C., Rha S.Y. A weighted sample size for microarray datasets that considers the variability of variance and multiplicity. J. Biosci. Bioeng. 2009, 108:252-258.
5. Ma X., Wang Z. Anticancer drug discovery in the future: an evolutionary perspective. Drug Discov. Today 2009, 14:1136-1142.
6. DeVita V.T., Chu E. A history of cancer chemotherapy. Cancer Res. 2008, 68:8643-8653.
7. Chabner B.A., Roberts T.G. Timeline: chemotherapy and the war on cancer. Nat. Rev. Cancer 2005, 5:65-72.
8. Cragg G.M., Grothaus P.G., Newman D.J. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 2009, 109:3012-3043.
9. Ravelo A.G., Estévez-Braun A., Chávez-Orellana H., Pérez-Sacau E., Mesa-Siverio D. Recent studies on natural products as anticancer agents. Curr. Top. Med. Chem. 2004, 4:241-265.
10. Liu J., Gunn L., Hansen R., Yan J. Yeast-derived beta-glucan in combination with anti-tumor monoclonal antibody therapy in cancer. Recent Pat. Anticancer Drug Discov. 2009, 4:101-109.
11. Robey R.W., Obrzut T., Shukla S., Polgar O., Macalou S., Bahr J.C., Di Pietro A., Ambudkar S.V., Bates S.E. Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells. Cancer Chemother. Pharmacol. 2009, 64:575-583.
12. Bertomeu T., Zvereff V., Ibrahim A., Zehntner S.P., Aliaga A., Rosa-Neto P., Bedell B.J., Falardeau P., Gourdeau H. TLN-4601 peripheral benzodiazepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulation. Biochem. Pharmacol. 2010, 80:1572-1579.
13. Kale A.J., McGlinchey R.P., Moore B.S. Characterization of 5-chloro-5-deoxy-D-ribose 1-dehydrogenase in chloroethylmalonyl coenzyme A biosynthesis: substrate and reaction profiling. J. Biol. Chem. 2010, 285:33710-33717.
14. Wang C., Wesener S.R., Zhang H., Cheng Y.Q. An FAD-dependent pyridine nucleotide-disulfide oxidoreductase is involved in disulfide bond formation in FK228 anticancer depsipeptide. Chem. Biol. 2009, 16:585-593.
15. Kumaran R.S., Kim H.J., Hur B.K. Taxol promising fungal endophyte, Pestalotiopsis species isolated from Taxus cuspidata. J. Biosci. Bioeng. 2010, 110:541-546.
16. Sakai T., Shindo K., Odagawa A., Suzuki A., Kawai H., Kobayashi K., Hayakawa Y., Seto H., Otake N. Absolute configuration of spicamycin, an antitumor antibiotic produced by Streptomyces alanosinicus. J. Antibiot. (Tokyo) 1995, 48:899-900.
17. Yamamoto M., Takakura A., Masuda N. Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin. Drug Des. Dev. Ther. 2009, 2:189-192.
18. Pérez M., Crespo C., Schleissner C., Rodríguez P., Zúñiga P., Reyes F. Tartrolon D, a cytotoxic macrodiolide from the marine-derived actinomycete Streptomyces sp. MDG-04-17-069. J. Nat. Prod. 2009, 72:2192-2194.
19. Konishi M., Sugawara K., Kofu F., Nishiyama Y., Tomita K., Miyaki T., Kawaguchi H. Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity. J. Antibiot. (Tokyo) 1986, 39:784-791.
20. Pearson L., Mihali T., Moffitt M., Kellmann R., Neilan B. On the chemistry, toxicology and genetics of the cyanobacterial toxins, microcystin, nodularin, saxitoxin and cylindrospermopsin. Mar. Drugs 2010, 8:1650-1680.
21. Jensen P.R., Williams P.G., Oh D.C., Zeigler L., Fenical W. Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora. Appl. Environ. Microbiol. 2007, 73:1146-1152.
22. Thornburg C.C., Zabriskie T.M., McPhail K.L. Deep-sea hydrothermal vents: potential hot spots for natural products discovery?. J. Nat. Prod. 2010, 73:489-499.
23. Fujiwara S. Extremophiles: developments of their special functions and potential resources. J. Biosci. Bioeng. 2002, 94:518-525.
24. Kroiss J., Kaltenpoth M., Schneider B., Schwinger M.G., Hertweck C., Maddula R.K., Strohm E., Svatos A. Symbiotic Streptomycetes provide antibiotic combination prophylaxis for wasp offspring. Nat. Chem. Biol. 2010, 6:261-263.
25. Kumaran R.S., Muthumary J., Hur B.K. Taxol from Phyllosticta citricarpa, a leaf spot fungus of the angiosperm Citrus medica. J. Biosci. Bioeng. 2008, 106:103-106.
26. D'Aoust J.Y., Gerber N.N. Isolation and purification of prodigiosin from Vibrio psychroerythrus. J. Bacteriol. 1974, 118:756-757.
27. Kawasaki T., Sakurai F., Hayakawa Y. A prodigiosin from the roseophilin producer Streptomyces griseoviridis. J. Nat. Prod. 2008, 71:1265-1267.
28. Fukuda K., Tamura T., Ito H., Yamamoto S., Ochi K., Inagaki K. Production improvement of antifungal, antitrypanosomal nucleoside sinefungin by rpoB mutation and optimization of resting cell system of Streptomyces incarnatus NRRL 8089. J. Biosci. Bioeng. 2010, 109:459-465.
29. Boonlarppradab C., Kauffman C.A., Jensen P.R., Fenical W. Marineosins A and B, cytotoxic spiroaminals from a marine-derived actinomycete. Org. Lett. 2008, 10:5505-5508.
30. Kim D., Lee J.S., Park Y.K., Kim J.F., Jeong H., Oh T.K., Kim B.S., Lee C.H. Biosynthesis of antibiotic PGs in the marine bacterium Hahella chejuensis KCTC 2396. J. Appl. Microbiol. 2007, 102:937-944.
31. Reapoport H., Holden K.G. The synthesis of prodigiosin. J. Am. Chem. Soc. 1961, 83:635-642.
32. Fürstner A. Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500years. Angew. Chem. Int. Ed. Engl. 2003, 42:3582-3603.
33. Pandey R., Chander R., Sainis K.B. Prodigiosins as anti cancer agents: living upto their name. Curr. Pharm. Des. 2009, 15:732-741.
34. Sevcikova B., Kormanec J. Differential production of two antibiotics of Streptomyces coelicolor A3(2), actinorhodin and undecylprodigiosin, upon salt stress conditions. Arch. Microbiol. 2004, 181:384-389.
35. Avignone Rossa C., White J., Kuiper A., Postma P.W., Bibb M., Teixeira de Mattos M.J. Carbon flux distribution in antibiotic-producing chemostat cultures of Streptomyces lividans. Metab. Eng. 2002, 4:138-150.
36. Sertan-de Guzman A.A., Predicala R.Z., Bernardo E.B., Neilan B.A., Elardo S.P., Mangalindan G.C., Tasdemir D., Ireland C.M., Barraquio W.L., Concepcion G.P. Pseudovibrio denitrificans strain Z143-1, a heptylprodigiosin-producing bacterium isolated from a Philippine tunicate. FEMS Microbiol. Lett. 2007, 277:188-196.
37. Sawabe T., Makino H., Tatsumi M., Nakano K., Tajima K., Iqbal M.M., Yumoto I., Ezura Y., Christen R. Pseudoalteromonas bacteriolytica sp. nov., a marine bacterium that is the causative agent of red spot disease of Laminaria japonica. Int. J. Syst. Bacteriol. 1998, 48:769-774.
38. Berg G. Diversity of antifungal and plant-associated Serratia plymuthica strains. J. Appl. Microbiol. 2000, 88:952-960.
39. Gerber N.N. Prodigiosin-like pigments. CRC. Crit. Rev. Microbiol. 1975, 3:469-485.
40. Allen G.R., Reichelt J.L., Gray P.P. Influence of environmental factors and medium composition on Vibrio gazogenes growth and prodigiosin production. Appl. Environ. Microbiol. 1983, 5:1727-1732.
41. Wei Y.H., Yu W.J., Chen W.C. Enhanced undecylprodigiosin production from Serratia marcescens SS-1 by medium formulation and amino-acid supplementation. J. Biosci. Bioeng. 2005, 100:466-471.
42. Wei Y.H., Chen W.C. Enhanced production of prodigiosin-like pigment from Serratia marcescens SMδR by medium improvement and oil-supplementation strategies. J. Biosci. Bioeng. 2005, 99:616-622.
43. Liu R., Cui C.B., Duan L., Gu Q.Q., Zhu W.M. Potent in vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Saccharopolyspora sp. nov. Arch. Pharm. Res. 2005, 28:1341-1344.
44. Rusanova E.P., Alekhova T.A., Fedorova G.B., Katrukha G.S. An antibiotic complex produced by Streptomyces werraensis 1365T strain. Prikl. Biokhim. Mikrobiol. 2000, 36:564-568.
45. Gerber N.N. Prodigiosin-like pigments from Actinomadura (Nocardia) pelletieri. J. Antibiot. (Tokyo) 1971, 24:636-640.
46. Gerber N.N. Prodigiosin-like pigments from Actinomadura (Nocardia) pelletieri and Actinomadura madurae. Appl. Microbiol. 1969, 18:1-3.
47. Cerdeño A.M., Bibb M.J., Challis G.L. Analysis of the prodiginine biosynthesis gene cluster of Streptomyces coelicolor A3(2): new mechanisms for chain initiation and termination in modular multienzymes. Chem. Biol. 2001, 8:817-829.
48. Gerber N.N., Lechevalier M.P. Prodiginine (prodigiosin-like) pigments from Streptomyces and other aerobic Actinomycetes. Can. J. Microbiol. 1976, 22:658-667.
49. Isaka M., Jaturapat A., Kramyu J., Tanticharoen M., Thebtaranonth Y. Potent in vitro antimalarial activity of metacycloprodigiosin isolated from Streptomyces spectabilis BCC 4785. Antimicrob. Agents Chemother. 2002, 46:1112-1113.
50. Wasserman H.H., Rodgers G.C., Keith D.D. Metacycloprodigiosin, a tripyrrole pigment from Streptomyces longisporus ruber. J. Am. Chem. Soc. 1969, 91:1263-1264.
51. Qadri S.M., Williams R.P. Induction of prodigiosin biosynthesis after shift-down in temperature of nonproliferating cells of Serratia marcescens. Appl. Microbiol. 1972, 23:704-709.
52. Giri A.V., Anandkumar N., Muthukumaran G., Pennathur G. A novel medium for the enhanced cell growth and production of prodigiosin from Serratia marcescens isolated from soil. BMC Microbiol. 2004, 4:1-10.
53. Willams R.P., Gott C.L., Qadri S.M. Induction of pigmentation in nonproliferating cells of Serratia marcescens by addition of single amino acids. J. Bacteriol. 1971, 106:444-448.
54. Cacace J.E., Mazza G. Extraction of anthocyanins and other phenolics from black currants with sulfured water. J. Agric. Food Chem. 2002, 50:5939-5946.
55. Heinemann B., Howard A.J., Palocz H.J. Influence of dissolved oxygen levels on production of L-asparginase and prodigiosin. Appl. Microbiol. 1970, 19:800-804.
56. Solé M., Francia A., Rius N., Lorén J.G. The role of pH in the 'glucose effect' on prodigiosin production by non-proliferating cells of Serratia marcescens. Lett. Appl. Microbiol. 1997, 25:81-84.
57. Solé M., Rius N., Francia A., Lorén J.G. The effect of pH on prodigiosin production by non-proliferating cells of Serratia marcescens. Lett. Appl. Microbiol. 1994, 19:341-344.
58. Solé M., Rius N., Lorén J.G. Rapid extracellular acidification induced by glucose metabolism in non-proliferating cells of Serratia marcescens. Int. Microbiol. 2000, 3:39-43.
59. Witney F.R., Failia M.L., Weinberg E.D. Phosphate inhibition of secondary metabolism in Serratia marcescens. Appl. Environ. Microbiol. 1977, 33:1024-1046.
60. Rjazantseva I.N., Andreeva I.N., Ogorodnikova T.I. Effect of various growth conditions on pigmentation of Serratia marcescens. Microbios 1994, 79:155-161.
61. Yamazaki G., Nishimura S., Ishida A., Kanagasabhapathy M., Zhou X., Nagata S., Morohoshi T., Ikeda T. Effect of salt stress on pigment production of Serratia rubidaea N-1: a potential indicator strain for screening quorum sensing inhibitors from marine microbes. J. Gen. Appl. Microbiol. 2006, 52:113-117.
62. Sevcikova B., Kormanec J. Differential production of two antibiotics of Streptomyces coelicolor A3(2), actinorhodin and undecylprodigiosin, upon salt stress conditions. Arch. Microbiol. 2004, 181:384-389.
63. Goldschmitt M.C., Williams R.P. Thiamin induced formation of the monopyrrole moiety of prodigiosin. J. Bacteriol. 1968, 96:609-616.
64. Silverman M.P., Munoz E.F. Effect of iron and salt on prodigiosin synthesis in Serratia marcescens. J. Bacteriol. 1973, 114:999-1006.
65. Lawanson A.O., Sholeye F.O. Inhibition of prodigiosin formation in Serratia marcescens by adenosine triphosphate. Experientia 1975, 32:439-440.
66. Li M., Kim T.J., Kwon H.J., Suh J.W. Effects of extracellular ATP on the physiology of Streptomyces coelicolor A3(2). FEMS Microbiol. Lett. 2008, 286:24-31.
67. Clements-Jewery S. The reversal of glucose repressed prodigiosin production in Serratia marcescens by the cyclic 3'5'-adenosine monophosphate inhibitor theophylline. Experientia 1976, 32:421-422.
68. Kalivoda E.J., Stella N.A., Aston M.A., Fender J.E., Thompson P.P., Kowalski R.P., Shanks R.M. Cyclic AMP negatively regulates prodigiosin production by Serratia marcescens. Res. Microbiol. 2010, 161:158-167.
69. Qadri S.M., Willams R.P. Role of methionine in biosynthesis of prodigiosin by Serratia marcescens. J. Bacteriol. 1973, 116:1191-1198.
70. Thomas M.G., Burket M.D., Walsh C.T. Conversion of L-proline to pyrrolyl-2-carboxyl-S-PCP during undecylprodigiosin and pyoluteorin biosynthesis. Chem. Biol. 2002, 9:171-184.
71. Williamson N.R., Simonsen H.T., Ahmed R.A.A., Goldet G., Slater H., Woodley L., Leeper F.J., Salmond G.P.C. Biosynthesis of the red antibiotic, prodigiosin, in Serratia: identification of a novel 2-methyl-3-n-amyl-pyrrole (MAP) assembly pathway, definition of the terminal condensing enzyme, and implications for undecylprodigiosin biosynthesis in Streptomyces. Mol. Microbiol. 2005, 56:971-989.
72. de Araújo H.W., Fukushima K., Takaki G.M. Prodigiosin production by Serratia marcescens UCP 1549 using renewable-resources as a low cost substrate. Molecules 2010, 15:6931-6940.
73. Harris A.K., Williamson N.R., Slater H., Cox A., Abbasi S., Foulds I., Simonsen H.T., Leeper F.J., Salmond G.P.C. The Serratia gene cluster encoding biosynthesis of the red antibiotic, prodigiosin, shows species- and strain-dependent genome context variation. Microbiology 2004, 150:3547-3560.
74. Williamson N.R., Simonsen H.T., Ahmed R.A.A., Goldet G., Slater H., Woodley L., Leeper F.J., Salmond G.P.C. Biosynthesis of the red antibiotic, prodigiosin, in Serratia: identification of a novel 2-methyl-3-n-amyl-pyrrole (MAP) assembly pathway, definition of the terminal condensing enzyme, and implications for undecylprodigiosin biosynthesis in Streptomyces. Mol. Microbiol. 2005, 56:971-989.
75. Dauenhauer S.A., Hull R.A., Williams R.P. Cloning and expression in Escherichia coli of Serratia marcescens genes encoding prodigiosin biosynthesis. J. Bacteriol. 1984, 158:1128-1132.
76. Williamson N.R., Simonsen H.T., Harris A.K., Leeper F.J., Salmond G.P. Disruption of the copper efflux pump (CopA) of Serratia marcescens ATCC 274 pleiotropically affects copper sensitivity and production of the tripyrrole secondary metabolite, prodigiosin. J. Ind. Microbiol. Biotechnol. 2006, 33:151-158.
77. Yamashita M., Nakagawa Y., Li H., Matsuyama T. Silica gel-dependent production of prodigiosin and serrawettins by Serratia marcescens in a liquid culture. Microbiol. Environ. 2001, 16:250-254.
78. Tanikawa T., Nakagawa Y., Matsuyama T. Transcriptional downregulator hexS controlling prodigiosin and serrawettin W1 biosynthesis in Serratia marcescens. Microbiol. Immunol. 2006, 50:587-596.
79. Kim S.J., Lee H.K., Yim J.H. Mutant selection of Hahella chejuensis KCTC 2396 and statistical optimization of medium components for prodigiosin yield-up. J. Microbiol. 2008, 46:183-188.
80. Sunaga S., Li H., Sato Y., Nakagawa Y., Matsuyama T. Identification and characterization of the pswP gene required for the parallel production of prodigiosin and serrawettin W1 in Serratia marcescens. Microbiol. Immunol. 2004, 48:723-728.
81. Borodina I., Siebring J., Zhang J., Smith C.P., van Keulen G., Dijkhuizen L., Nielsen J. Antibiotic overproduction in Streptomyces coelicolor A3(2) mediated by phosphofructokinase deletion. J. Biol. Chem. 2008, 283:25186-25199.
82. Kang S.G., Jin W., Bibb M., Lee K.J. Actinorhodin and undecylprodigiosin production in wild-type and relA mutant strains of Streptomyces coelicolor A3(2) grown in continuous culture. FEMS Microbiol. Lett. 1998, 168:221-226.
83. Song M.J., Bae J., Lee D.S., Kim C.H., Kim J.S., Kim S.W., Hong S.I. Purification and characterization of prodigiosin produced by integrated bioreactor from Serratia sp. KH-95. J. Biosci. Bioeng. 2006, 101:157-161.
84. Kim C.H., Kim S.W., Hong S.I. Isolation and characteristics of prodigiosin-like red pigment produced by Serratia sp. KH-95. Korean J. Appl. Microbiol. Biotechnol. 1998, 26:283-289.
85. Kim C.H., Kim S.W., Hong S.I. An integrated fermentation-separation process for the production of red pigment by Serratia sp. KH-95. Process Biochem. 1999, 35:485-490.
86. Bae J., Moon H., Oh K.K., Kim C.H., Lee D.S., Kim S.W., Hong S.I. A novel bioreactor with an internal adsorbent for integrated fermentation and recovery of prodigiosin-like pigment produced from Serratia sp. KH-95. Biotechnol. Lett. 2001, 23:1315-1319.
87. Syzdek L.D. Influence of Serratia marcescens pigmentation on cell concentrations in aerosols produced by bursting bubbles. Appl. Environ. Microbiol. 1985, 4:173-178.
88. Weiss C.M. Spectrophotometric and chromatographic analyses of the pigment produced by members of the genus Serratia. J. Cell. Comp. Physiol. 1949, 34:467-492.
89. Feng J.S., Webb J.W., Tsang J.C. Enhancement by sodium dodecyl sulfate of pigment formation in Serratia marcescens O8. Appl. Environ. Microbiol. 1982, 43:850-853.
90. Mallick S.A. Cell surface hydrophobicity and its relation to outer membrane proteins of Serratia marcescens. Indian J. Exp. Biol. 1996, 134:107-110.
91. Pérez-Tomás R., Viñas M. New insights on the antitumoral properties of prodiginines. Curr. Med. Chem. 2010, 17:2222-2231.
92. Yamamoto C., Takemoto H., Kuno K., Yamamoto D., Tsubura A., Kamata K., Hirata H., Yamamoto A., Kano H., Seki T., Inoue K. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice. Hepatology 1999, 30:894-902.
93. Zhang J., Shen Y., Liu J., Wei D. Antimetastatic effect of prodigiosin through inhibition of tumor invasion. Biochem. Pharmacol. 2005, 69:407-414.
94. Campàs C., Dalmau M., Montaner B., Barragán M., Bellosillo B., Colomer D., Pons G., Pérez-Tomás R., Gil J. Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia. Leukemia 2003, 17:746-750.
95. Soto-Cerrato V., Llagostera E., Montaner B., Scheffer G.L., Pérez-Tomás R. Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin. Biochem. Pharmacol. 2004, 68:1345-1352.
96. Ho T.F., Ma C.J., Lu C.H., Tsai Y.T., Wei Y.H., Chang JS., Lai J.K., Cheuh P.J., Yeh C.T., Tang P.C., Tsai Chang J., Ko J.L., Liu F.S., Yen H.E., Chang C.C. Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53. Toxicol. Appl. Pharmacol. 2007, 225:318-328.
97. Lagadic-Gossmann D., Huc L., Lecureur V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 2004, 11:953-961.
98. Ohkuma S., Sato T., Okamoto M., Matsuya H., Arai K., Kataoka T., Nagai K., Wasserman H.H. Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport. Biochem. J. 1998, 334:731-741.
99. Yamamoto D., Uemura Y., Tanaka K., Nakai K., Yamamoto C., Takemoto H., Kamata K., Hirata H., Hioki K. Cycloprodigiosin hydrochloride, H(+)/Cl(-) symporter, induces apoptosis and differentiation in HL-60 cells. Int. J. Cancer 2000, 88:121-128.
100. Montaner B., Pérez-Tomás R. The cytotoxic prodigiosin induces phosphorylation of p38-MAPK but not of SAPK/JNK. Toxicol. Lett. 2002, 129:93-98.
101. Castillo-Avila W., Abal M., Robine S., Pérez-Tomás R. Non-apoptotic concentrations of prodigiosin (H+/Cl- symporter) inhibit the acidification of lysosomes and induce cell cycle blockage in colon cancer cells. Life Sci. 2005, 78:121-127.
102. Cory S., Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2:647-656.
103. Schimmer A.D., Dalili S., Batey R.A., Riedl S.J. Targeting XIAP for the treatment of malignancy. Cell Death Differ. 2006, 13:179-188.
104. Altieri D.C. Survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer 2008, 8:61-70.
105. Ho T.F., Peng Y.T., Chuang S.M., Lin S.C., Feng B.L., Lu C.H., Yu W.J., Chang J.S., Chang C.C. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines. Toxicol. Appl. Pharmacol. 2009, 235:253-260.
106. Hunter A.M., LaCasse E.C., Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007, 12:1543-1568.
107. Peng X.H., Karna P., O'Regan R.M., Liu X., Naithani R., Moriarty R.M., Wood W.C., Lee H.Y., Yang L. Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells. Mol. Pharmacol. 2007, 71:101-111.
108. Menendez D., Inga A., Resnick M.A. The expanding universe of p53 targets. Nat. Rev. Cancer 2009, 9:724-737.
109. Manderville R.A. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products. Curr. Med. Chem. Anticancer Agents 2001, 1:195-218.
110. Montaner B., Castillo-Avila W., Martinell M., Ollinger R., Aymami J., Giralt E., Pérez-Tomás R. DNA interaction and dual topoisomerase I and II inhibition properties of the anti-tumor drug prodigiosin. Toxicol. Sci. 2005, 85:870-879.
111. Ramoneda B.M., Pérez-Tomás R. Activation of protein kinase C for protection of cells against apoptosis induced by the immunosuppressor prodigiosin. Biochem. Pharmacol. 2002, 63:463-469.
112. Soto-Cerrato V., Viñals F., Lambert J.R., Kelly J.A., Pérez-Tomás R. Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3beta activity in human breast cancer cells. Mol. Cancer Ther. 2007, 6:362-369.
113. Songia S., Mortellaro A., Taverna S., Fornasiero C., Scheiber E.A., Erba E., Colotta F., Mantovani A., Isetta A.M., Golay J. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets. J. Immunol. 1997, 158:3987-3995.
114. Pérez-Tomás R., Montaner B. Effects of the proapoptotic drug prodigiosin on cell cycle-related proteins in Jurkat T cells. Histol. Histopathol. 2003, 18:379-385.
115. Soto-Cerrato V., Viñals F., Lambert J.R., Pérez-Tomás R. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway. Biochem. Pharmacol. 2007, 4:1340-1349.